DFO
RETA
Duquesne Family Office’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-58,997
| Closed | -$2.24M | – | 76 |
|
|
2022
Q4 | $2.24M | Hold |
58,997
| – | – | 0.11% | 49 |
|
|
2022
Q3 | $1.48M | Hold |
58,997
| – | – | 0.08% | 57 |
|
|
2022
Q2 | $1.79M | Hold |
58,997
| – | – | 0.13% | 34 |
|
|
2022
Q1 | $1.93M | Sell |
58,997
-347,267
| -85% | -$11.4M | 0.08% | 46 |
|
|
2021
Q4 | $10.7M | Sell |
406,264
-288,769
| -42% | -$7.61M | 0.39% | 27 |
|
|
2021
Q3 | $69.9M | Buy |
695,033
+57,689
| +9% | +$5.8M | 2.27% | 12 |
|
|
2021
Q2 | $90.2M | Sell |
637,344
-112,553
| -15% | -$15.9M | 2.23% | 14 |
|
|
2021
Q1 | $74.8M | Hold |
749,897
| – | – | 1.65% | 17 |
|
|
2020
Q4 | $92.7M | Buy |
749,897
+205,996
| +38% | +$25.5M | 2.5% | 13 |
|
|
2020
Q3 | $53M | Buy |
543,901
+11,023
| +2% | +$1.07M | 1.54% | 19 |
|
|
2020
Q2 | $83.1M | Buy |
532,878
+1,000
| +0.2% | +$156K | 2.54% | 14 |
|
|
2020
Q1 | $76.8M | Buy |
531,878
+105,159
| +25% | +$15.2M | 3.11% | 11 |
|
|
2019
Q4 | $87.2M | Buy |
426,719
+253,434
| +146% | +$51.8M | 2.56% | 12 |
|
|
2019
Q3 | $13.9M | Buy |
+173,285
| New | +$13.9M | 0.54% | 29 |
|